Theranexus
A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Theranexus is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company develops drug candidates for the treatment of rare neurological and central nervous system (CNS) diseases. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates, focusing on the key role of non-neuronal cells (glial cells) to enhance therapeutic efficacy. The company's pipeline includes a drug candidate in clinical development for Batten disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-14 18:30 |
Regulatory News Service
THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIA…
|
English | 212.6 KB | ||
| 2025-10-14 18:30 |
Regulatory News Service
THX PHARMA (THERANEXUS) ET EXELTIS FRANCHISSENT UNE ÉTAPE MAJEURE VERS LA COMME…
|
French | 186.1 KB | ||
| 2025-09-29 18:30 |
Regulatory News Service
Theranexus devient THX Pharma : une évolution stratégique vers la commercialisa…
|
French | 211.7 KB | ||
| 2025-09-29 18:30 |
Regulatory News Service
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercializati…
|
English | 209.9 KB | ||
| 2025-05-13 18:00 |
Regulatory News Service
THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-W…
|
English | 391.8 KB | ||
| 2025-05-13 18:00 |
Business and Financial Review
THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE R…
|
French | 352.9 KB | ||
| 2025-04-29 19:05 |
Registration Form
URD 2024
|
French | 10.6 MB | ||
| 2025-04-29 19:00 |
Earnings Release
THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT A…
|
English | 336.5 KB | ||
| 2025-04-29 19:00 |
Earnings Release
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS E…
|
French | 297.3 KB | ||
| 2025-03-06 18:00 |
Regulatory News Service
MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
|
French | 272.5 KB | ||
| 2025-01-23 18:15 |
Report Publication Announcement
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
|
English | 262.8 KB | ||
| 2025-01-23 18:00 |
Report Publication Announcement
THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2025
|
French | 254.5 KB | ||
| 2025-01-16 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total de droits de vote et d'actions c…
|
French | 168.8 KB | ||
| 2025-01-09 18:00 |
Report Publication Announcement
THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS
|
English | 179.9 KB | ||
| 2025-01-09 18:00 |
Report Publication Announcement
THERANEXUS ANNONCE LA PUBLICATION DE SA LETTRE AUX ACTIONNAIRES
|
French | 181.7 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
